loading
前日終値:
$48.89
開ける:
$48.7
24時間の取引高:
344.38K
Relative Volume:
0.66
時価総額:
$2.92B
収益:
-
当期純損益:
$-145.21M
株価収益率:
-20.73
EPS:
-2.3
ネットキャッシュフロー:
$-140.12M
1週間 パフォーマンス:
+0.76%
1か月 パフォーマンス:
+1.45%
6か月 パフォーマンス:
-5.28%
1年 パフォーマンス:
+13.16%
1日の値動き範囲:
Value
$46.86
$49.15
1週間の範囲:
Value
$46.24
$49.29
52週間の値動き範囲:
Value
$31.42
$58.26

Moonlake Immunotherapeutics Stock (MLTX) Company Profile

Name
名前
Moonlake Immunotherapeutics
Name
セクター
Healthcare (1165)
Name
電話
41 41 510 8022
Name
住所
DORFSTRASSE 29, ZUG
Name
職員
100
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
MLTX's Discussions on Twitter

MLTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MLTX
Moonlake Immunotherapeutics
47.64 2.92B 0 -145.21M -140.12M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.76 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
537.58 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.65 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.30 28.51B 3.81B -644.79M -669.77M -6.24

Moonlake Immunotherapeutics Stock (MLTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-19 アップグレード Wolfe Research Peer Perform → Outperform
2025-03-18 開始されました RBC Capital Mkts Outperform
2025-01-17 アップグレード Goldman Neutral → Buy
2024-11-05 再開されました Wedbush Outperform
2024-08-26 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 開始されました Oppenheimer Outperform
2024-04-02 開始されました Goldman Neutral
2024-02-15 開始されました Wolfe Research Outperform
2023-12-08 開始されました Citigroup Buy
2023-11-02 開始されました Stifel Buy
2023-09-14 ダウングレード Bryan Garnier Buy → Neutral
2023-08-31 開始されました Needham Buy
2023-06-15 開始されました Barclays Equal Weight
2023-05-01 開始されました Guggenheim Buy
2023-03-22 開始されました Wedbush Outperform
2023-03-09 開始されました BTIG Research Buy
2023-02-14 開始されました Cantor Fitzgerald Overweight
2023-02-02 開始されました Bryan Garnier Buy
2022-11-11 開始されました Jefferies Buy
2022-08-25 開始されました SVB Leerink Outperform
2022-07-21 開始されました H.C. Wainwright Buy
2022-07-07 開始されました Cowen Outperform
すべてを表示

Moonlake Immunotherapeutics (MLTX) 最新ニュース

pulisher
Jun 18, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Challenges - geneonline.com

Jun 18, 2025
pulisher
Jun 16, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Developments - geneonline.com

Jun 16, 2025
pulisher
Jun 15, 2025

Learn to Evaluate (MLTX) using the Charts - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 15, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Developments - geneonline.com

Jun 15, 2025
pulisher
Jun 13, 2025

MoonLake Immunotherapeutics’ SWOT analysis: nanobody firm’s stock poised for pivotal phase III data - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

IIH interview: Matthias Bodenstedt discusses MoonLake’s capital raising journey, the appeal of SLK and plans for the future - Investors in Healthcare

Jun 13, 2025
pulisher
Jun 13, 2025

MoonLake Immunotherapeutics: Strategic Positioning and Promising Clinical Developments Drive Buy Rating - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Focus on Inflammatory Disease Treatments - geneonline.com

Jun 12, 2025
pulisher
Jun 10, 2025

MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Biotech Sector Focus - geneonline.com

Jun 10, 2025
pulisher
Jun 09, 2025

MoonLake Immunotherapeutics (MLTX) Hosts Investor Meetings Amid Merger Speculation | MLTX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Stat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics - TipRanks

Jun 09, 2025
pulisher
Jun 08, 2025

StockWatch: Report of $3B+ Merck Buyout Offer Propels MoonLake Stock Surge - Genetic Engineering and Biotechnology News

Jun 08, 2025
pulisher
Jun 07, 2025

MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

MoonLake Immunotherapeutics Reportedly Exploring Potential Sale Amid Strategic Uncertainty - geneonline.com

Jun 07, 2025
pulisher
Jun 07, 2025

MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

MoonLake Immunotherapeutics Elects Directors at AGM - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Merck held talks to buy biotech MoonLake for over $3 billion - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

These Stocks Moved the Most Today: Nvidia, Tesla, Dollar General, Credo, Ferguson, Moonlake, and More - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

MoonLake Immunotherapeutics Reportedly Exploring Potential Sale Amid Industry Speculation - geneonline.com

Jun 06, 2025
pulisher
Jun 05, 2025

A MoonLake Buyout Would Boost Merck & Co’s Immunology Ambitions - insights.citeline.com

Jun 05, 2025
pulisher
Jun 05, 2025

MoonLake Immunotherapeutics Reportedly Considering Sale Amid Competitive Pharmaceutical Market Challenges - geneonline.com

Jun 05, 2025
pulisher
Jun 05, 2025

MoonLake Immunotherapeutics is for sale? This sounds like a cry for help - statnews.com

Jun 05, 2025
pulisher
Jun 04, 2025

Merck's Bold Proposal Sends MoonLake's Shares Climbing - Finimize

Jun 04, 2025
pulisher
Jun 04, 2025

Merck made $3B+ offer for MoonLake earlier this yearreport - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Two Biotechs That Could Get an M&A Boost - TheStreet Pro

Jun 04, 2025
pulisher
Jun 04, 2025

Merck & Co., Inc. (MRK) Held Talks Over $3 Billion Acquisition of Swiss Biotech Firm MoonLake - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Merck in Talks to Acquire MoonLake Immunotherapeutics for $3 Billion - geneonline.com

Jun 04, 2025
pulisher
Jun 04, 2025

MSD rumoured to be eyeing $3bn+ MoonLake takeover - pharmaphorum

Jun 04, 2025
pulisher
Jun 03, 2025

MoonLake Immunotherapeutics (MLTX) Surges 25% on Merck Acquisiti - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake Immunotherapeutics Catapults On Rumored $3 Billion Merck Takeover Bid - Investor's Business Daily

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest (MLTX) - Seeking Alpha

Jun 03, 2025
pulisher
Jun 03, 2025

Merck Offers Over $3 Billion to Acquire MoonLake Immunotherapeutics Amid Industry Shifts - geneonline.com

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake Immunotherapeutics Breaks Above 200-Day Moving AverageBullish for MLTX - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake's (MLTX) 'Outperform' Rating Reiterated by RBC Capital - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake takeover thesis reemerges after FT report, says Citi - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake Shares Jump On Potential Merck Acquisition Offer - Finimize

Jun 03, 2025
pulisher
Jun 03, 2025

MoonLake Immunotherapeutics: Strong Acquisition Interest and Promising Product Pipeline Drive Buy Rating - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital maintains outperform rating on Moonlake stock By Investing.com - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital maintains outperform rating on Moonlake stock - Investing.com

Jun 03, 2025

Moonlake Immunotherapeutics (MLTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Moonlake Immunotherapeutics (MLTX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BVF PARTNERS L P/IL
Director
Oct 04 '24
Sale
50.00
2,000,000
100,003,200
1,287,768
Sturge Simon
Director
Oct 04 '24
Sale
53.72
171,000
9,186,120
171,980
$20.42
price up icon 0.84%
$36.14
price down icon 0.47%
$23.52
price down icon 8.23%
$95.22
price down icon 1.94%
$110.60
price up icon 0.50%
biotechnology ONC
$242.65
price down icon 0.20%
大文字化:     |  ボリューム (24 時間):